Ocular Therapeutix shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Ocular Therapeutix (OCUL) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Ocular Therapeutix
Tip: Access up to 7 years of quarterly data
All positions including Ocular Therapeutix held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ocular Therapeutix by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $2.6M | 309k | 8.47 |
| 2025-12-31 | $3.7M | 308k | 12.14 |
| 2025-09-30 | $2.4M | 201k | 11.69 |
| 2025-06-30 | $2.9M | 316k | 9.28 |
| 2025-03-31 | $1.6M | 213k | 7.33 |
| 2024-12-31 | $1.9M | 219k | 8.54 |
| 2024-09-30 | $1.3M | 148k | 8.70 |
| 2024-06-30 | $1.3M | 186k | 6.84 |
| 2022-03-31 | $501k | 101k | 4.95 |
| 2021-12-31 | $551k | 79k | 6.97 |
| 2021-09-30 | $686k | 69k | 10.00 |
| 2021-06-30 | $1.1M | 75k | 14.18 |
| 2021-03-31 | $1.0M | 62k | 16.41 |
| 2020-12-31 | $1.0M | 50k | 20.70 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas